Aims & Scope
Current Drug Safety publishes frontier articles on all the latest advances in drug safety. The journal aims to publish the highest quality research articles, full-length/mini reviews and case reports in the field. Topics covered include adverse effects of individual drugs and drug classes, management of adverse effects, pharmacovigilance and pharmacoepidemiology of new and existing drugs, and post-marketing surveillance. It also includes articles focused on resources for identification of harmful substances and cellular, biochemical, and molecular mechanisms which are responsible for the side effects of drugs. The journal is an essential reading for all researchers and clinicians involved in drug safety.
British Library, Cambridge Scientific Abstracts (CSA)/ProQuest, Chemical Abstracts Service/SciFinder, ChemWeb, CNKI Scholar, Dimensions, EBSCO, EMBASE, EMCare, Emerging Sources Citation Index (ESCI) by Clarivate Analytics, Genamics JournalSeek, Google Scholar, J-Gate, JournalTOCs, MediaFinder®-Standard Periodical Directory, MEDLINE/PubMed, Open Abstracts (I4OA), Norwegian Register, PubsHub, QOAM, Scopus, Suweco CZ, TOC Premier, and Ulrich's Periodicals Directory.
Current Drug Safety Journal was launched in 2006. Dr. Seetal Dodd serves as the Editor-in-Chief of the journal.
Quick processing and publication of the submitted papers. The manuscript will be published online within 20 days of final acceptance.
30% discount on the single-issue cost to authors on the purchase of issue(s) in which their article is published.
Multiple issue copies at discounted rates.
Our experience with Bentham Science Publishers was excellent. Replies were quick and clear and we will be happy to work with you again when possible. Thank you for your help and assistance.
Dr. Alina Poperno
(Enfocement and Inspection Division, Israeli Ministry of Health, Eliav 9, Jerusalem 9546208, Israel)
Has contributed: A Case of Hepatotoxicity Induced by Adulterated “Tiger King”, a Chinese Herbal Medicine Containing Sildenafil